MetaStat Inc
MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the … Read more
MetaStat Inc (MTST) - Total Assets
Latest total assets as of February 2018: $729.63K USD
Based on the latest financial reports, MetaStat Inc (MTST) holds total assets worth $729.63K USD as of February 2018.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
MetaStat Inc - Total Assets Trend (2008–2018)
This chart illustrates how MetaStat Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
MetaStat Inc - Asset Composition Analysis
Current Asset Composition (February 2018)
MetaStat Inc's total assets of $729.63K consist of 45.5% current assets and 54.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 43.4% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $354.10K | 48.5% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2008–2018)
This chart illustrates how MetaStat Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: MetaStat Inc's current assets represent 45.5% of total assets in 2018, an increase from 45.5% in 2008.
- Cash Position: Cash and equivalents constituted 43.4% of total assets in 2018, up from 16.4% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 14.0% in 2008.
- Asset Diversification: The largest asset category is property, plant & equipment at 48.5% of total assets.
MetaStat Inc Competitors by Total Assets
Key competitors of MetaStat Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
MetaStat Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - MetaStat Inc generates 0.03x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - MetaStat Inc is currently not profitable relative to its asset base.
MetaStat Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.16 | 0.41 | 0.82 |
| Quick Ratio | 0.16 | 0.41 | 0.82 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-1.75 Million | $ -1.15 Million | $ -220.03K |
MetaStat Inc - Advanced Valuation Insights
This section examines the relationship between MetaStat Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -42.2% |
| Total Assets | $729.63K |
| Market Capitalization | $578.52 USD |
Valuation Analysis
Below Book Valuation: The market values MetaStat Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: MetaStat Inc's assets decreased by 42.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for MetaStat Inc (2008–2018)
The table below shows the annual total assets of MetaStat Inc from 2008 to 2018.
| Year | Total Assets | Change |
|---|---|---|
| 2018-02-28 | $729.63K | -42.18% |
| 2017-02-28 | $1.26 Million | +18.75% |
| 2016-02-29 | $1.06 Million | -3.59% |
| 2015-02-28 | $1.10 Million | +39.40% |
| 2014-02-28 | $790.62K | -22.68% |
| 2013-02-28 | $1.02 Million | -41.99% |
| 2012-02-29 | $1.76 Million | +304.05% |
| 2008-02-29 | $436.22K | -- |